Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.

Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531. Pediatr Blood Cancer. 2024 Aug; 71(8):e31089.

View in: PubMed

subject areas

Adolescent
Antineoplastic Combined Chemotherapy Protocols
Child
Child, Preschool
Female
Follow-Up Studies
Humans
Infant
Infant, Newborn
Male
Neoplasm Staging
Neuroblastoma
Prognosis
Survival Rate

authors with profiles

Susan Cohn